Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Bempedoic Acid Pregnancy Surveillance Program

A Post-marketing, Long-term, Observational, Descriptive Study to Assess the Risk of Pregnancy and Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Women Exposed to Bempedoic Acid or Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) During Pregnancy

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Bempedoic acid pregnancy surveillance program

Who May Be Eligible (Plain English)

Who May Qualify: Exposure to at least 1 dose of bempedoic acid or bempedoic acid/ezetimibe FCDP at any time during pregnancy (from first day of last menstrual period \[LMP\] to pregnancy outcome Who Should NOT Join This Trial: Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: Exposure to at least 1 dose of bempedoic acid or bempedoic acid/ezetimibe FCDP at any time during pregnancy (from first day of last menstrual period \[LMP\] to pregnancy outcome Exclusion Criteria:

Treatments Being Tested

DRUG

Bempedoic Acid

Bempedoic Acid 180 MG

DRUG

Bempedoic Acid / Ezetimibe

Bempedoic Acid 180 MG / Ezetimibe 10 MG

Locations (1)

Evidera, PPD business unit
Morrisville, North Carolina, United States